Targeted HPMA copolymer-bound doxorubicin conjugates in the treatment of established tumors and induction of effective anti-tumor immunity

Number of the records: 1

1.

SYSNO ASEP	0099613
Document Type	C - Proceedings Paper (int. conf.)
R&D Document Type	Conference Paper
Title	Targeted HPMA copolymer-bound doxorubicin conjugates in the treatment of established tumors and induction of effective anti-tumor immunity
Title	Indukce efektivní protinádorové imunity při léčbě směrovaným konjugátem na bázi poly(HPMA) obsahujícím doxorubicin
Author(s)	Kovář, Marek (MBU-M)_{RID, ORCID} Tomala, Jakub (MBU-M)_{RID, ORCID} Mrkvan, Tomáš (MBU-M) Etrych, Tomáš (UMCH-V)_{RID, ORCID} Strohalm, Jiří (UMCH-V) Ulbrich, Karel (UMCH-V)_RID Říhová, Blanka (MBU-M)_RID
Source Title	International Workshop on Drug Delivery Systems /5./. - Praha : Springer, 2007
Pages	s. 25-25
Number of pages	1 s.
Action	International Workshop on Drug Delivery Systems /5./
Event date	15.05.2007-18.5.2007
VEvent location	Třeštˇ
Country	CZ - Czech Republic
Event type	WRD
Language	eng - English
Country	CZ - Czech Republic
Keywords	hpma
Subject RIV	EC - Immunology
R&D Projects	GP301/07/P192 GA ČR - Czech Science Foundation (CSF)
CEZ	AV0Z50200510 - MBU-M (2005-2011)
	AV0Z40500505 - UMCH-V (2005-2011)
Annotation	Thus, treatment with B1 mAb-targeted conjugates is able to completely cured BCL 1 bearing mice and most importantly, break immunoescaping mechanisms of BCL1 cells
Workplace	Institute of Microbiology
Contact	Eliška Spurná, eliska.spurna@biomed.cas.cz, Tel.: 241 062 231
Year of Publishing	2008

Number of the records: 1